Medicine
Provocholine 100 mg/100 mg inhalation powder
Provocholine 100 mg/100 mg inhalation powder is a prescription medicine containing Methacholine for inhalation use, marketed by Methapharm, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store the supplied powder at 59°F to 86°F (15°C to 30°C). Store ready-to-use…
Key facts
- Active ingredient (INN)
- Methacholine
- Brand
- Provocholine
- Strength
- 100 mg/100 mg
- Dosage form
- Inhalation powder
- Route
- Inhalation
- Packs
- 6 vials
- Marketing authorisation holder
- Methapharm
- Manufacturer
- Methapharm
- Origin register
- US FDA, United States
- Storage
- Store the supplied powder at 59°F to 86°F (15°C to 30°C). Store ready-to-use kits and single-dose vials between 15°C to 25°C (59°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 March 2013
- Identifiers
- DailyMed set ID e8983096-65e6-41f2-8b6f-bbf0a7227307NDC 64281-100Application NDA019193
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 vial, glass in 1 box / 100 mg in 1 vial, glass | 64281-100-06 | Methapharm | 27 March 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 October 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Methacholine
Clinical summary
Methacholine is a cholinergic receptor agonist indicated for the diagnosis of bronchial airway hyperreactivity in adults and pediatric patients five years of age and older who do not have clinically apparent asthma. MedsAcross supplies Methacholine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethacholineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Provocholine prescribing information (Methapharm) · U.S. National Library of Medicine, DailyMed
Need Provocholine 100 mg/100 mg inhalation powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.